CD8A and neoplasm: A previous study showed that a significant reduction in the number of CD4+ and CD8+ tumour-infiltrating lymphocytes (TILs) during non-classical differentiation in advanced BC may be associated with lower tumour immunogenicity and immune tolerance towards cancer and that a decrease in CD4+ TILs was indicative of poor prognosis [21].